M

MTF Biologics

Nonprofit coordinating tissue and organ donation

Tissue Recovery Technician

Part-TimeDeadline 9/22/27
$18/hr
Junior, Mid
Associate's
Syracuse, NY, USA
In PersonMust reside in Syracuse, New York.
Medical, Clinical & Veterinary

About the job

Requirements
  • A high school diploma or GED is required.
  • One to three years of experience is required.
  • A health or surgical background is required.
  • Knowledge of gross anatomy and PC literacy is required.
Responsibilities
  • Coordinate, perform, and monitor all aspects of the tissue recovery process, including ocular recovery when applicable, according to MTF or other processor policies.
  • Facilitate teamwork and problem solving in support of MTF’s mission.
  • Collaborate with MTF Donor Coordination on referral, screening, and authorization.
  • Interact with recovery teams, hospitals, emergency medical services, medical examiners, and funeral directors throughout the recovery process.
  • Collect medical charts, laboratory data, blood specimens, and other relevant data from recovery sites and appropriate agencies; review information to establish donor suitability and maintain records according to policy.
  • Document donor records accurately, complete charts through chart release, identify necessary corrections for the appropriate personnel, and assist with maintaining donor records under Quality Assurance policies and procedures.
  • Evaluate processes continuously to improve recovery operations for MTF and referral sources or donor accounts.
  • Build and maintain professional relationships with staff from MTF, coroner and medical examiner offices, hospitals, organ procurement organizations, processors, and funeral homes.
  • Attend and participate in corporate, clinical, and other designated meetings.
  • Provide call coverage approximately 14–21 days per month, including weekends and holidays, according to assigned schedules or business needs.
  • Complete and maintain assigned work, including training manuals, materials management, vehicle maintenance, and the monthly on-call calendar.
  • Assist the manager with recruiting, hiring, orienting, and training new staff.
  • Complete other assigned duties, including special projects.
Desired Qualifications
  • An associate degree is preferred.
  • One to five years of experience is preferred.
  • LPN, RN, surgical technician, or MD credentials are preferred.
  • Knowledge of an operating-room environment, sterile technique, gross and fine anatomy, and tissue banking experience are preferred.

About the company

MTF Biologics is a global nonprofit that coordinates tissue and organ donation, transplantation, and related research through a network of organ procurement and tissue recovery organizations and academic medical centers. It connects donor families with medical teams, recovers and processes donated tissues and organs, and supports implantation and transplantation across its partner institutions while funding studies to improve outcomes. Unlike for-profit competitors, it operates as a mission-driven consortium that prioritizes saving lives over commercial sales. Its goal is to increase safe tissue and organ donation, improve transplant results, and advance research in transplantation and tissue science.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Edison, New Jersey

Founded

1987

Get referred to MTF Biologics

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • June 4, 2026 FlexHD Meshed removes intraoperative prep and shortens reconstructive procedures.
  • May 21, 2026 New Horizon distribution expands AmnioBand into post-acute and outpatient channels.
  • December 17, 2025 CMS coverage for AmnioBand and AlloPatch supports reimbursement and adoption.

What critics are saying

  • 2026 breast-mesh filings name FlexHD, threatening costly discovery and settlement pressure.
  • Donor-supply disruptions or recovery setbacks instantly constrain product availability and operating throughput.
  • Kolosis partnerships shift commercialization leverage outward, weakening MTF control over orthobiologics adoption.

What makes MTF Biologics unique

  • Nonprofit, physician-led MTF Biologics honors donated gifts and advances tissue transplantation.
  • June 2026 FlexHD Meshed widens a deep reconstructive portfolio for complex wounds.
  • Its 1987 grant program funds translational allograft science, reinforcing clinical credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Health Savings Account/Flexible Spending Account
  • Paid Vacation
  • Paid Holidays
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Tuition Reimbursement
  • Adoption Assistance

Company News

Business Wire
Jun 4th, 2026
MTF Biologics launches FlexHD Meshed for reconstructive surgery

MTF Biologics, a global nonprofit organisation focused on tissue transplantation, has launched FlexHD® Meshed, an extension of its FlexHD® reconstructive surgery portfolio. The pre-meshed acellular dermis matrix is designed for soft tissue defects, addressing irregular wound geometries and accelerating coverage for graft incorporation. The product eliminates the need for intraoperative preparation, reducing operating room time whilst providing immediate coverage that conforms to irregular anatomy. FlexHD® Meshed is cut from a deeper layer of dermis and aseptically processed to ensure superior handling and clinical efficacy. Developed in collaboration with surgeons treating complex wounds and deep tissue injuries, the allograft provides a structural scaffold that supports cellular repopulation and tissue integration. The product is now available through MTF Biologics.

Yahoo Finance
Apr 29th, 2026
MTF Biologics appoints Dorrie Dils to board, names David McAllister vice chair

MTF Biologics, a global nonprofit organisation focused on tissue and organ donation and transplantation, has appointed Ladora (Dorrie) Dils to its Board of Directors and named David McAllister as Vice Chair. Dils brings over three decades of experience in organ donation, currently serving as President and Chief Executive Officer of Gift of Life Michigan since 2024. She previously spent more than 20 years at Lifeline of Ohio, rising to Chief Clinical Officer. Dils is also Immediate Past President of the Association of Organ Procurement Organizations and has served on the Organ Procurement and Transplantation Network's Board of Directors. "Her expertise will be pivotal as we consider additional ways to support clinicians in saving and healing lives", said Joe Yaccarino, MTF Biologics' President and Chief Executive Officer.

Business Wire
Mar 31st, 2026
MTF Biologics and Kolosis launch DBX Fiber to expand demineralized bone matrix portfolio

MTF Biologics and Kolosis BIO have launched DBX Fiber, a new demineralized bone matrix product designed for complex spinal and orthopaedic procedures. The fibre tissue form is processed to provide surgeons with enhanced handling and osteoinductive potential in challenging fusion environments. DBX Fiber expands the existing DBX portfolio, which already includes DBX Mix and DBX Putty. The addition strengthens Kolosis' surgical biologics portfolio, which features products such as Kore Fiber, a cortical bone allograft, and Summit Matrix, a synthetic bone graft. MTF Biologics is a global nonprofit organisation focused on tissue and organ donation, transplantation and research. Kolosis BIO specialises in commercialising surgical biologics technologies across spine and orthopaedic procedures. The partnership aims to provide surgeons with greater versatility whilst maintaining trusted biologics solutions.

Business Wire
Jan 14th, 2026
MTF Biologics and Kolosis BIO launch Summit Matrix synthetic bone graft for spinal surgeries

MTF Biologics, a global nonprofit tissue and organ donation organisation, and Kolosis BIO have launched Summit Matrix, an advanced synthetic bone graft for orthopedic and spinal surgeries. The product uses NanoLift surface technology, combining nanoscale topography with biomimetic chemistry to enhance bone regeneration. Summit Matrix integrates with existing products including Kore Fiber, Prime HD and DBX Mix. Its hydroxycarbanoapatite composition mimics natural bone mineral, enabling optimal resorption and osseointegration. The nanocrystalline surface supports cell activity to promote bone formation. The launch expands the partnership between MTF Biologics, founded by orthopedic surgeons nearly 40 years ago, and Kolosis BIO, which has established itself as a leading orthobiologics provider. Together, the organisations aim to deliver innovative solutions that enhance surgical efficiency and clinical practice.

Business Wire
Mar 27th, 2024
Dr. Mia Talmor Joins The Mtf Biologics Board Of Directors

Dr. Mia Talmor, Professor of Clinical Surgery at The Weill Cornell Medical School and attending surgeon at New York Presbyterian Hospital, has joined the MTF Biologics Board of Directors. (Photo: Business Wire)Dr. Mia Talmor, Professor of Clinical Surgery at The Weill Cornell Medical School and attending surgeon at New York Presbyterian Hospital, has joined the MTF Biologics Board of Directors. (Photo: Business Wire)EDISON, N.J.--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation, has announced the appointment of Mia Talmor, MD, to the MTF Biologics Board of Directors.“We are honored to welcome Dr. Talmor to the MTF Board,” said William W